Study Summary
The main purpose of this research is to verify the safety of CD19 targeted chimeric antigen receptor T cells and to determine the proper dosage of CAR T cells infused.
Want to learn more about this trial?
Request More InfoInterventions
Chimeric Antigen Receptor Modified T cells Targeting CD19BIOLOGICAL
T cells modified with CD19 targeted chimeric antigen receptor.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Southwest Hospital of Third Millitary Medical University | Chongqing | Chongqing Municipality | China |